tiprankstipranks
Advertisement
Advertisement

NVCR Stock Latest News

NovoCure Shareholders Approve Directors, Auditor and Incentive Plan
Company AnnouncementsNovoCure Shareholders Approve Directors, Auditor and Incentive Plan
6d ago
8K
NVCR
NovoCure Earnings Call Highlights Growth, One-Time Hit
PremiumCompany Announcements
NovoCure Earnings Call Highlights Growth, One-Time Hit
22d ago
NVCR
Novocure price target raised to $17 from $13.50 at Wells Fargo
PremiumThe Fly
Novocure price target raised to $17 from $13.50 at Wells Fargo
1M ago
NVCR
Novocure price target raised to $20 from $16 at Evercore ISI
PremiumThe Fly
Novocure price target raised to $20 from $16 at Evercore ISI
1M ago
NVCR
NovoCure Earnings Call Highlights Growth, One-Time Hit
PremiumCompany Announcements
NovoCure Earnings Call Highlights Growth, One-Time Hit
1M ago
NVCR
Midday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
PremiumThe FlyMidday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
1M ago
UL
CAT
Novocure reports Q1 EPS (62c), consensus (51c)
Premium
The Fly
Novocure reports Q1 EPS (62c), consensus (51c)
1M ago
NVCR
Novocure raises FY26 revenue view to $690M-$710M from $675M-$705M
Premium
The Fly
Novocure raises FY26 revenue view to $690M-$710M from $675M-$705M
1M ago
NVCR
NovoCure Expands Executive Role, Adjusts CMO Compensation
PremiumCompany Announcements
NovoCure Expands Executive Role, Adjusts CMO Compensation
2M ago
8K
NVCR
Novocure price target lowered to $16 from $23 at Evercore ISI
PremiumThe Fly
Novocure price target lowered to $16 from $23 at Evercore ISI
2M ago
NVCR
Zymeworks appoints Kristin Stafford as CFO
PremiumThe Fly
Zymeworks appoints Kristin Stafford as CFO
2M ago
NVCR
ZYME
NovoCure’s EF-32 Optune® Trial Reaches Completion, Setting Up a Key Catalyst for NVCR Investors
PremiumCompany Announcements
NovoCure’s EF-32 Optune® Trial Reaches Completion, Setting Up a Key Catalyst for NVCR Investors
2M ago
NVCR
NovoCure Announces Positive Phase 2 PANOVA-4 Pancreatic Cancer Data
PremiumCompany AnnouncementsNovoCure Announces Positive Phase 2 PANOVA-4 Pancreatic Cancer Data
3M ago
8K
NVCR
Novocure announces results from Phase 2 PANOVA-4 trial met primary endpoint
Premium
The Fly
Novocure announces results from Phase 2 PANOVA-4 trial met primary endpoint
3M ago
NVCR
Novocure gets reimbursement approval in Japan for Optune Lua
Premium
The Fly
Novocure gets reimbursement approval in Japan for Optune Lua
3M ago
NVCR
Novocure gets reimbursement approval in Japan for Optune Lua
PremiumThe Fly
Novocure gets reimbursement approval in Japan for Optune Lua
3M ago
NVCR
NovoCure Earnings Call: Growth Builds Amid Profit Strain
PremiumCompany Announcements
NovoCure Earnings Call: Growth Builds Amid Profit Strain
3M ago
NVCR
Novocure reports Q4 EPS (22c), consensus (41c)
PremiumThe Fly
Novocure reports Q4 EPS (22c), consensus (41c)
4M ago
NVCR
Novocure sees FY26 revenue $675M-$705M, consensus $681.24M
PremiumThe Fly
Novocure sees FY26 revenue $675M-$705M, consensus $681.24M
4M ago
NVCR
Novocure says CMS rescinds revocation of billing privileges
PremiumThe FlyNovocure says CMS rescinds revocation of billing privileges
4M ago
NVCR
Novocure jumps 11% after CMS reinstates Medicare billing privileges
Premium
The Fly
Novocure jumps 11% after CMS reinstates Medicare billing privileges
4M ago
NVCR
NovoCure Has Medicare Billing Privileges Reinstated by CMS
Premium
Company Announcements
NovoCure Has Medicare Billing Privileges Reinstated by CMS
4M ago
8K
NVCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >